CardioGenics Holdings (CardioGenics Holdings) EPS (Basic) : $-0.01 (TTM As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings EPS (Basic)?

CardioGenics Holdings's basic earnings per share (Basic EPS) for the three months ended in Jan. 2016 was $-0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jan. 2016 was $-0.01.

CardioGenics Holdings's EPS (Diluted) for the three months ended in Jan. 2016 was $-0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2016 was $-0.01.

CardioGenics Holdings's EPS without NRI for the three months ended in Jan. 2016 was $-0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2016 was -0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

CardioGenics Holdings EPS (Basic) Historical Data

The historical data trend for CardioGenics Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings EPS (Basic) Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

EPS (Basic)

Get a 7-Day Free Trial

-0.11

-0.02

-0.05

-0.04

-0.02

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
EPS (Basic)	Get a 7-Day Free Trial															-0.01	-	-0.01	-	-

CardioGenics Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

CardioGenics Holdings's Basic EPS for the fiscal year that ended in Oct. 2015 is calculated as

Basic EPS (A: Oct. 2015 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-1.916	-	0)	/	94.424
	=	-0.02

CardioGenics Holdings's Basic EPS for the quarter that ended in Jan. 2016 is calculated as

Basic EPS (Q: Jan. 2016 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.125	-	0)	/	116.716
	=	-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2016 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

CardioGenics Holdings (OTCPK:CGNH) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

CardioGenics Holdings EPS (Basic) Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines